The AAIC experience is defined by a diverse scientific program that offers more than 600 podium presentations focusing on basic science and pathogenesis, biomarkers, clinical manifestations, drug development, public health, and dementia care, as well as more than 2,900 posters on the latest dementia research.
More information about the AAIC 2024 program is coming soon.
On This Page:
Plenary Sessions address the field’s most crucial and compelling topics and are delivered by leaders in the field. The Alzheimer's Association was pleased to welcome distinguished plenary speakers to AAIC 2023:
Tau PET: Towards Implementation in Trials and Clinical Practice
Presented by Rik Ossenkoppele — Netherlands and Sweden
Bassoon Contributes to Tau-seed Propagation and Neurotoxicity
Presented by Cristian Lasagna-Reeves — United States
The Evolving Role of Complement in Alzheimer’s Disease
Presented by Cynthia Lemere — United States
The Aphasic Dementia of Alzheimer’s Disease
Presented by Marsel Mesulam — United States
The Epidemiology of Dementia in Africa
Presented by Adesola Ogunniyi — Nigeria
Amyloid Reduction and Evidence of Downstream Biomarker Modification
An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities
Presented by Ana Quiñones — United States
Inclusion in Research and Clinical Trials
Presented by Goldie Byrd — United States
Perspectives Sessions provide expert reviews of recent advances and propose a road map for the future, incorporating multiple viewpoints to stimulate original discussion and debate. Perspectives Sessions at AAIC 2023 included:
Featured Research Sessions (FRS) debut and discuss innovative and impactful research findings, drawing together multiple studies that share a common focus.
Join ISTAART, an inclusive global network of scientists, clinicians and dementia professionals. With newly discounted rates and free memberships for students, it’s easier than ever to become a part of ISTAART.